Reverse engineering carries a reputation problem in medical device circles; it sounds like copying. In practice, it’s a legitimate engineering discipline with specific, defensible use cases: replacing obsolete components, improving an existing design’s manufacturability, and indigenizing imported parts. This article looks at when reverse engineering genuinely makes sense in medical device development, the technical process involved, and the intellectual property considerations teams need to navigate before using it.
What Reverse Engineering Actually Means in This Context
Reverse engineering, in a medical device context, is the process of analyzing an existing part, assembly, or product to understand its design, function, and manufacturing method usually to recreate, replace, or improve it, rather than to simply copy it wholesale.
This distinction matters. Reverse engineering an obsolete bracket to keep a legacy ventilator running is a fundamentally different activity, both technically and legally, from reverse engineering a competitor’s patented device to bring a near-identical product to market. The former is a common, accepted engineering practice. The latter raises serious intellectual property concerns and is not what this article is describing.
With that distinction in mind, there are three situations where reverse engineering is routinely and legitimately used in medical device engineering, summarized in Table 1 below and discussed in detail after.
Table 1: Three Legitimate Use Cases for Reverse Engineering in Medical Devices
| Situation | Typical Trigger | Primary Goal |
| Replacing obsolete components | Original supplier discontinues a part the device depends on | Functional continuity, minimal regulatory disruption |
| Improving manufacturability | Legacy design needs to scale to higher-volume production | Updated tolerances/materials while preserving original function |
| Indigenizing imported components | High cost or unreliable lead times on imported parts | Locally manufacturable, functionally equivalent alternative |
Situation One: Replacing Obsolete or Discontinued Components
Medical devices frequently outlive their component suppliers. A device approved and in active clinical use ten years ago¹ may depend on a microcontroller, connector, or mechanical part that the original manufacturer no longer produces. Since the device itself may still have years of useful service life and recertifying an entirely new device is neither fast nor cheap the practical path is often to reverse engineer the obsolete component and source or manufacture a functionally equivalent replacement.
This process typically starts with physical measurement (using calipers, CMMs, or 3D scanning for mechanical parts) combined with functional testing to understand tolerances, materials, and performance characteristics that aren’t always documented. For electronic components, this can mean reverse engineering a circuit’s function without needing to replicate proprietary internal designs focusing on interface compatibility rather than internal architecture.
The goal here isn’t innovation; it’s continuity. A well-executed obsolescence replacement should be functionally indistinguishable from the original part, which also simplifies the regulatory conversation, since the device’s core function and risk profile haven’t changed.
Situation Two: Improving an Existing Design’s Manufacturability
Sometimes reverse engineering is applied to a company’s own legacy product, one that was originally designed years ago, before the company had access to better manufacturing processes, materials, or design tools. In this case, the “reverse engineering” is really a structured process of documenting an existing, working design (which may only exist as physical parts and outdated drawings) before re-engineering it for current manufacturing methods.
This is common when a device was originally designed for low-volume production perhaps using manual machining or basic tooling and the company now needs to scale to higher volumes with injection-molded or more automated production. The original design intent and function are preserved, but geometry, tolerances, and material specifications are re-derived and updated to suit modern manufacturing constraints. In effect, the team reverse engineers their own product to build an accurate, current baseline before applying design-for-manufacturing improvements.
This situation also arises frequently in technology transfer projects, where a device developed by one team or facility needs to be manufactured by another that lacks complete original design documentation.
Situation Three: Indigenizing Imported Components
For medical device companies operating in markets like India, a significant share of specialized components, sensors, connectors, specific polymers, precision-machined parts are imported, often at high cost and with long, sometimes unreliable lead times. Reverse engineering is frequently used to develop a locally manufacturable, functionally equivalent alternative to an imported part, reducing both cost and supply chain risk.
This process requires particular care. The goal is functional and dimensional equivalence not visual or brand replication and the resulting part typically needs to go through its own validation and, depending on its role in the device, potentially its own regulatory documentation, even though it’s replacing a component rather than being a new device in itself.
The Technical Process, in Practice
Regardless of which situation applies, the reverse engineering process for a physical medical device component generally follows a similar structure:
First, the part or assembly is measured and documented through 3D scanning, CMM measurement, or careful manual measurement for simpler geometries to capture accurate dimensional data.
Second, materials are identified, either through documentation (if available) or material testing, since replicating a part’s geometry without matching its material properties (strength, biocompatibility, sterilization resistance) can produce a part that looks correct but fails functionally.
Third, the part is functionally tested under realistic conditions to understand tolerances and performance margins that pure measurement won’t reveal a part might measure identically to the original but behave differently under load, temperature, or repeated use.
Fourth, a new CAD model and manufacturing specification are developed based on this data, along with the same design-for-manufacturing considerations that would apply to any new part design.
Throughout this process, documentation is critical not just for internal engineering purposes, but because regulatory bodies will typically want evidence that the replacement or improved part has been shown to be functionally equivalent to what it replaces, not simply assumed to be.
It’s worth noting that reverse engineering rarely produces an identical replica, and that’s usually fine. The goal is functional equivalence, not an exact copy. A replacement fastener might use a different manufacturing process than the original (machined versus molded, for instance) as long as it meets the same mechanical requirements. In some cases, the reverse engineering process even surfaces opportunities for genuine improvement, a part that was originally over-engineered for a manufacturing process no longer in use, for example, can sometimes be simplified once its actual functional requirements are properly understood, rather than just inherited from the original design.
Intellectual Property Considerations
This is where reverse engineering requires genuine caution, and where the line between “legitimate engineering practice” and “IP infringement” needs to be understood clearly before starting.
Reverse engineering a part to understand its function and interface without copying protected design elements, without infringing active patents, and without violating any contractual or confidentiality obligations is generally defensible engineering practice in most jurisdictions. This is particularly true for the obsolescence and indigenization use cases described above, where the intent is functional replacement rather than replicating a competitor’s proprietary innovation.
However, if the original component or design is covered by an active patent, or if there’s a contractual relationship (such as an NDA with the original supplier) that restricts this kind of analysis, reverse engineering can create real legal exposure. Before starting a reverse engineering effort, it’s worth confirming: Is the original component or design still under active patent protection? Is there any contractual relationship with the original manufacturer that restricts this analysis? Is the goal genuinely functional replacement, or does it risk replicating protected design elements unnecessarily?
Teams that skip this step treating reverse engineering as a purely technical exercise are the ones most likely to run into IP problems later, often well after significant engineering investment has already been made.
A related, and often overlooked, consideration is documentation of the reverse engineering process itself. Keeping a clear record of what was independently measured and derived as opposed to what may have been referenced from existing technical documentation can matter significantly if the legitimacy of the work is ever questioned. This is particularly relevant in the obsolescence use case, where a company may later need to demonstrate to a regulatory body, or in rarer cases a court, that a replacement part was developed through independent engineering analysis rather than through improper access to a competitor’s proprietary design files.
Conclusion
Reverse engineering, applied to the right problems, is a practical and often necessary part of sustaining and improving medical devices over their lifecycle particularly as components become obsolete, as manufacturing needs evolve, and as supply chains globalize. The technical process is well established. What separates a defensible reverse engineering project from a risky one is less about the engineering itself and more about clarity of intent, thorough documentation, and an honest IP review before work begins.
References
- U.S. Food and Drug Administration, “Medical Device Component Obsolescence,” FDA Guidance Documents.
- World Intellectual Property Organization, “Reverse Engineering and Patent Law: An Overview,” WIPO.int.
- Association for the Advancement of Medical Instrumentation (AAMI), “Managing Legacy Medical Device Component Risk.”
The post Reverse Engineering in Medical Device Design: When and Why It Makes Sense appeared first on MedTech Intelligence.